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A commentary on
Theta isoantigen as a marker of thymus-
derived lymphocytes in mice
by Raff MC. Nature (1969) 224:378–9.
Two distinct populations of peripheral
lymphocytes in mice distinguishable by
immunofluorescence
by Raff MC. Immunology (1970) 19:637–50.
I began my scientific career in October
1968 at the National Institute for Medical
Research (NIMR) in London. I was 30-
years old, having just finished my training
in clinical neurology in Boston, and I had
come to work with Avrion (Av) Mitchi-
son. I had much to learn, as I had done no
basic research and knew very little about
immunology.
It was an exciting time – both in
immunology and at the NIMR. There was
increasing evidence that there were two
types of lymphocytes, T and B cells, respon-
sible for adaptive immune responses but
there were no good ways to distinguish or
separate them. Av had recently heard the
Boston immunologist Arnold Reif describe
a mouse isoantigen called theta (θ), which
was present in the brain and on the sur-
face of thymocytes (1, 2). Av wondered if
θ might be present on T but not B cells, in
which case it could serve as a useful cell-
surface marker for mouse T cells. He gave
me the relevant Reif papers, an aliquot of a
mouse anti-θ antiserum that he had begun
making, and set me free.
In a commentary written in 2008 for the
Pillars of Immunology series in the Jour-
nal of Immunology (3), the Seattle immu-
nologist Pamela Fink colorfully described
what happened next. Here, I give an
abbreviated account of this history but
broaden it to include the fortuitous find-
ing that immunoglobulin (Ig) can serve as
a cell-surface marker for B cells.
To detect θ on mouse lymphocytes, I
first used an antibody- and complement-
dependent 51chromium-release cytotoxic-
ity assay, which I learned from my lab-mate
Marion Ruskowicz (4). I found that the
antiserum and complement killed essen-
tially all thymus lymphocytes but only a
subset of lymph node and spleen lympho-
cytes. To test whether the θ-positive lym-
phocytes in lymph node and spleen were
T cells, I analyzed cells from pathogen-
free mice that had been treated since
birth with a rabbit antiserum made against
mouse thymocytes (5) and were there-
fore T-cell-depleted; Sandra Nehlson, a
Ph.D. student with Peter Medawar who
worked across the hall, generously provided
these mice. I found that the spleen and
lymph nodes of the mice contained nor-
mal numbers of θ-negative lymphocytes
but greatly reduced numbers of θ-positive
lymphocytes, strongly suggesting that Av’s
hunch was right – θ is present on T but
not B cells (6). Schlesinger and Yron inde-
pendently published very similar findings
around the same time (7); unfairly, their
paper received far less attention, proba-
bly because its title lacked the punch line
of their findings. Later, in collaboration
with Henry Wortis, who worked next door,
we confirmed these findings in other T-
cell-deficient mice, including congenitally
athymic nude mice (8).
I then tested the functional properties of
θ-positive spleen cells by analyzing the cells
involved in an adoptive cell-transfer system
that Av had developed to study the coop-
eration between two populations of spleen
cells – one from mice immunized with a
hapten (NIP) coupled to a carrier protein
(chicken γ-globulin, CGG) and another
from mice immunized with an uncoupled,
second carrier protein (bovine serum albu-
min, BSA). He had shown that, when both
cell populations, but not either one alone,
are transferred into a sub-lethally irradi-
ated mouse, the recipient mouse produces
large amounts of anti-NIP antibodies in the
blood when immunized with NIP-BSA but
not with NIP-CGG – an example of the so-
called carrier effect (9). In my experiments,
before transferring the cells, I treated one
or other population with anti-θ antibodies
and complement to kill the T cells, using
normal mouse serum plus complement as
a control. In this way, I could show that
the relevant cells in the BSA-immunized
population were T cells, whereas the rel-
evant cells in the NIP-CGG-immunized
population, which produced the anti-NIP
antibodies (9), were not (10). This experi-
ment provided direct evidence that T cells
recognizing antigenic determinants on a
protein can help B cells make antibod-
ies against different antigenic determinants
on the same protein (11). It also estab-
lished the value of antibodies that recognize
cell-type-specific surface antigens, which
rapidly became standard tools in immunol-
ogy and, later, in various other branches of
biology.
Remarkably,Av declined to put his name
on these two Nature papers (6, 10), even
though the projects were his idea and he
had begun to produce anti-θ antibodies
before I arrived in London. This excep-
tional generosity had an enormous influ-
ence on my career. Theta (now called Thy-
1) rapidly became a standard marker for
mouse T cells, and the two single-author
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Nature papers gave me immediate interna-
tional recognition, after only 2 years doing
basic science. Nonetheless, if I had known
then what I know now, I would have
insisted that Av’s name was on the papers,
to indicate his crucial contributions to
the work. Av always did his own experi-
ments and made many landmark contri-
butions to immunology; because he usually
allowed his students and postdoctoral fel-
lows to publish on their own, however, his
actual contributions are far greater than are
documented in the literature.
To visualize θ directly on the surface
of living T cells, I turned from cytotoxi-
city assays to immunofluorescence exper-
iments. In these experiments, I visualized
the bound mouse anti-θ antibodies using
fluorescent rabbit anti-mouse-Ig antibod-
ies. A surprise came from control experi-
ments in which I omitted the anti-θ anti-
bodies and found that the fluorescent anti-
Ig antibodies on their own labeled a sub-
stantial proportion of lymphocytes in cell
suspensions prepared from various periph-
eral lymphoid organs, although not in
suspensions of thymocytes. Roger Taylor,
working across the hall with Michel Stern-
berg, had independently obtained similar
results using radiolabeled anti-mouse-Ig
antibodies, and we published our find-
ings together (12). Although a number
of immunologists, including Av, had sus-
pected that the antigen receptors on lym-
phocytes might be Ig proteins, ours was
one of the first direct demonstrations of Ig
molecules on the surface of lymphocytes.
The finding of Ig on some periph-
eral lymphocytes but not others raised
the question of which class of lymphocyte
expressed the cell-surface Ig. To find out,
I studied lymphocytes from normal mice
and from various T-cell-depleted mice,
labeling the cells with anti-mouse-Ig anti-
bodies, with or without first labeling them
with mouse anti-θ antibodies. The results
were unambiguous: the Ig-positive cells
were θ-negative, implying that they were
B cells, whereas the θ-positive T cells were
Ig-negative (13). (The analysis was greatly
helped by the fact that the Ig was distrib-
uted in a cap at one pole of the B cells,
whereas θ was distributed as a ring on the
T cells; later, Stefanello de Petris and I, and
Roger Taylor and Phillip Duffus indepen-
dently, showed that the binding of the anti-
Ig antibodies induces the B cells to actively
redistribute their surface Ig molecules into
a cap (14) – but that is another story.) The
Journal of Experimental Medicine rejected
my paper as not being sufficiently interest-
ing, and it was published in Immunology,
a low impact journal. Despite this (and its
unhelpful title), it became a Citation Clas-
sic (15), which taught me an important
lesson: it is what you publish rather than
where you publish it that matters most. The
finding of Ig on the surface of B cells but not
T cells led to a prolonged and frustrating
search by many laboratories for the anti-
gen receptors on T cells, which were only
identified as distinct Ig-like proteins years
later, after a number of false leads (16).
Cell-surface Ig became a standard mark-
er for B cells in all vertebrates. When I
moved with Av to University College Lon-
don, for example, John Owen and I col-
laborated with Max Cooper (who was on
sabbatical from the University of Alabama)
and used anti-Ig antibodies and explant
cultures to study the development of B cells.
We showed that mouse B cells develop in
the fetal liver and adult bone marrow (17),
rather than in gut-associated lymphoid tis-
sues as had been proposed by Max and oth-
ers. We later used Max’s class-specific anti-
Ig antibodies to demonstrate that the B cells
arise from pre-B cells, which have already
begun to make IgM heavy chains (18).
Remarkably, these first few years in
science were the most productive in my
research career. This early success was
largely the result of good luck: I was at the
right place at the right time, with a gener-
ous and inspiring mentor. And it was why I
became a scientist rather than a practicing
neurologist.
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